This Group Learning activity has been certified by the College of Family Physicians of Canada for up to 2.75 Mainpro+® certified credits.

Members of the American Academy of Family Physicians are eligible to receive up to 2.75 Prescribed credit hours for attendance at this meeting/event due to a reciprocal agreement with the College of Family Physicians of Canada

Overall Learning Objectives:

1. Recognize and diagnose fatty liver disease, including MASLD and MASH, in at-risk patient populations through appropriate screening and assessment tools.

2. Select and interpret appropriate diagnostic investigations to evaluate suspected cases of fatty liver disease.

3. Implement evidence-based treatment strategies for patients with hepatic steatosis, tailoring interventions to individual risk profiles and disease severity.

4. Identify and refer patients with advanced or high-risk fatty liver disease to specialized care for further management

MODERATOR: RICK WARD

Thursday, December 4, 2025
6:00 PM - 6:05 PM
 
6:05 PM - 6:30 PM
  • Define MASLD and MASH using current, practical terminology.
  • Identify key screening criteria and risk factors for fatty liver disease in primary care.
  • Summarize updated guidelines and nomenclature relevant to MASLD and MASH.
6:30 PM - 7:00 PM
  • Select appropriate laboratory and non-invasive tests for the assessment of fatty liver disease.
  • What labs to order
  • Demonstrate how to integrate liver health assessments into routine patient visits.
  • Interpret results from NITs (FIB-4, Transient Elastography, ultrasound, ELF, and non-invasive scores) and determine when to use each tool.
  • Apply workflow strategies to optimize efficiency and improve patient care in primary care settings.
7:00 PM - 7:25 PM
  • Describe common barriers patients face in accessing care for MASLD/MASH (e.g., stigma, confusion, fear).
  • Discuss patient experiences and factors that contributed to successful management.
  • Assess the impact of primary care interventions on patient outcomes.
7:25 PM - 7:55 PM
  • Addressing real world nutritional advice – Practical strategies for Primary Care
  • Addressing real world exercise advice - Practical strategies for Primary Care
  • Recommend practical nutritional and lifestyle strategies for patients with fatty liver disease.
  • Address patient challenges and stigma related to lifestyle modification.
  • Demonstrate brief, effective lifestyle interventions suitable for busy clinical settings
7:55 PM - 8:25 PM
  • Review the role of GLP-1s, statins, insulin sensitizers, and emerging therapies in MASLD/MASH management.
  • Evaluate medication choices considering comorbidities such as T2D, obesity, CKLM and bariatric surgery
  • Summarize current and upcoming guidelines for pharmacologic management.
8:25 PM - 8:55 PM
  • Analyze real-world cases to identify appropriate diagnostic and management strategies for diabetes and obesity
  • Evaluate patient with advanced fibrosis on Transient Elastography but no symptoms
  • Evaluate Young patient with obesity and normal liver enzymes
  • Differentiate between patients who require specialist referral and those manageable in primary care.
  • Formulate individualized care plans based on case scenarios.
8:55 PM - 9:00 PM
 
Time Zone: (UTC-04:00) Eastern Time (US & Canada) [Change Time Zone]

*Content subject to changes

Naim Alkhouri
Naim Alkhouri
Texas Liver Institute
James Kim
James Kim
Physician
University of Calgary
Melina Manolas
Melina Manolas
Endocrinologist
Weill Cornell Medicine
Lisa Schaffer
Lisa Schaffer
Executive Director
Obesity Canada
Kerry Sivia
Kerry Sivia
Patient Advocate
Fatty Liver Alliance
Rick Ward
Rick Ward
Clinical Associate Professor
University of Calgary
Jonathan Stine
Jonathan Stine
Clinical Professor of Medicine
Penn State Health Milton S. Hershey Medical Center
Michael Betel
Michael Betel
President and Founder
Fatty Liver Alliance
Mark Swain
Mark Swain
Professor of Medicine
University of Calgary
Alnoor Ramji
Alnoor Ramji
Clinical Associate Professor
University of British Columbia
Gina Madison
Gina Madison
Executive Director
Liver Education Advocates
Bruce Dimmig
Bruce Dimmig
Liver Advocate
Banner Liver Support Group
Stephanie Gysel
Stephanie Gysel
Clinical Pharmacist
University of Alberta
Ian Patton
Ian Patton
Director of Advocacy and Public Engagement
Obesity Canada